Scheme 1From: MiR26a reverses enzalutamide resistance in a bone-tumor targeted system with an enhanced effect on bone metastatic CRPCSchematic illustrations of the construction and mechanism of action of Bm@PT/Enz-miR26a in Bone-tumor microenvironmentBack to article page